Objective To observe the curative effect of diltiazem combined with low molecular weight heparins on chronic pulmonary heart disease (CPHD).
目的观察地尔硫联合低分子肝素治疗慢性肺源性心脏病的疗效。
The results showed that most heparins were covalently bound to the functional groups of blend film and the heparinized film had high antithrom…
结果表明，肝素化后的丝素改性胶原膜具有良好的抗凝血性。
Included in the options are low molecular weight heparins (LMWHs), synthetic pentasaccharides, adjusted-dose warfarin, aspirin, and mechanical prophylaxis.
包括低分子肝素（LMWHs），合成的戊多糖，调整剂量的华法林，阿斯匹林以及物理预防措施。
Methods Compare the effect on anticoagulant therapy, hemodialysis and the side effect from the use of heparin with those from the use of Low Molecular Weight Heparins.
方法：对比使用肝素与使用低分子肝素在血液透析中的抗凝效果，透析效果及其副作用。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
These results suggested that some chemically modified heparins with low anticoagulant activity may be used to inhibit the metastasis which induced by the interaction between tumor cells and platelets.
本文结果提示，经化学修饰后的低抗凝血肝素可以用于诘抗由肿瘤细胞与血小板相互作用导致的肿瘤转移。
These results suggested that some chemically modified heparins with low anticoagulant activity may be used to inhibit the metastasis which induced by the interaction between tumor cells and platelets.
本文结果提示，经化学修饰后的低抗凝血肝素可以用于诘抗由肿瘤细胞与血小板相互作用导致的肿瘤转移。
应用推荐